Trials / Withdrawn
WithdrawnNCT04904718
Real World Evaluation of Advisor Pro in Clinical Practice
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 6 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
To assess the integration of the DreaMed Advisor Pro tool into a real-world clinical practice using both in person and virtual visits to assess benefits in glycemia, as measured by the glucose management indicator and other glucose metrics. To determine acceptability of the DreaMed Advisor Pro tool both from a person with diabetes as well as a health care provider perspective. To quantify the potential reimbursement potential that could be generated with use of the DreaMed Advisor Pro.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DreaMed Advisor Pro | Advisor Pro software is a proprietary algorithm, designed to provide a comprehensive analysis of individual diabetes data consisting of glucose levels, insulin delivery history and meal consumption reported |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-05-27
- Last updated
- 2022-01-05
Source: ClinicalTrials.gov record NCT04904718. Inclusion in this directory is not an endorsement.